Lecture Week 6 Heart Failure and Diuretics Flashcards
Digoxin (Lanoxin) class
cardiac glycoside
Digoxin (Lanoxin) Therapeutic Use
management of mild to moderate heart failure in adults and children
also controls the ventricular response rate in adults with chronic atrial fibrillation
Digoxin (Lanoxin) EPA
improves the contractility and pumping ability of the heart by increasing calcium and inhibiting sodium and potassium
Digoxin (Lanoxin) ADRs
digoxin toxicity - cardiac dysrhythmias
Digoxin (Lanoxin) Interventions and Education
give 1 hr prior to antacid
hold for pulse <60
slow IV push >5 mins
monitor serum levels
educate on toxicity symptoms
take at same time - do not skip or double dose
Digoxin (Lanoxin) contraindications and interactions
ventricular dysrhythmias, AV block, severe heart disease
higher risk for toxicity in children and older adults
digoxin toxicity
dysrhythmias and bradycardia, heart blocks
nausea and vomiting
abdominal pain
blurry, yellow-tinted, vision or halos
reversal agent for digoxin toxicity
digibind (digoxin immune fab)
Dobutamine class
Inotropic Agent sympathomimetics
Dobutamine therapeutic use
severe heart failure, should only be short term use
Dobutamine EPA
Beta-1 adrenergic agonist = increased inotropy = increased cardiac output
Dobutamine ADRs
tachycardia
dysrhythmias
anginal pain
Dobutamine interventions and education
cardiac monitoring
continuous VS
monitor urine output
Dobutamine interactions
MAOI and tricyclic antidepressants
general anesthesia
Milrinone class
Inotropic Agent
Phosphodiesterase Inhibitor